SCHEMBL11350067

SCHEMBL11350067

O=C(Nc1ccc(C(=O)Nc2cc(S(=O)(=O)O)cc3ccc(O)cc23)cc1)Nc1ccc(C(=O)Nc2cc(S(=O)(=O)O)cc3ccc(O)cc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TIMP3 P35625 4/20 0.57
▸ FGF1 P05230 1/20 0.52
▸ PRMT1 Q99873 1/20 0.51
▸ ENPP2 Q13822 3/20 0.51
▸ CASP6 P55212 1/20 0.49
▸ CTDSP1 Q9GZU7 1/20 0.49
▸ APEX1 P27695 1/20 0.49
▸ TRPV1 Q8NER1 7/20 0.47
▸ NT5E P21589 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ F11 P03951 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10905209 0.93 ENPP2 (0.51) TIMP3FGF1PRMT1ENPP2CASP6
SCHEMBL11352224 0.91 PRMT1 (0.57) TIMP3FGF1PRMT1ENPP2CASP6
SCHEMBL11337363 0.87 TIMP3 (0.61) TIMP3PRMT1APEX1TRPV1MEN1
SCHEMBL11427680 0.87 CASP6 (0.59) TIMP3PRMT1ENPP2CASP6CTDSP1
SCHEMBL11339174 0.84 HPSE (0.46) TIMP3PRMT1ENPP2APEX1TRPV1
SCHEMBL10905294 0.83 CASP6 (0.55) TIMP3FGF1PRMT1ENPP2CASP6
SCHEMBL11417274 0.83 PRMT1 (0.49) TIMP3PRMT1ENPP2TRPV1NT5E
SCHEMBL11343949 0.83 ENPP2 (0.56) TIMP3FGF1PRMT1ENPP2CASP6
SCHEMBL11436268 0.83 MAPT (0.57) ENPP2APEX1TRPV1MEN1ALDH1A1
SCHEMBL11352189 0.81 TIMP3 (0.57) TIMP3FGF1PRMT1ENPP2CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 — — US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 — — EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
Send feedback